Literature DB >> 12432186

Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication.

Pier Alberto Testoni1.   

Abstract

The reported incidence of post-ERCP/sphincterotomy pancreatitis ranges between 1.3 and 24.4% in non-selected series. This varying incidence likely reflects on the one hand difference in patient populations, indications and endoscopic expertise and, on the other hand, different definitions of pancreatitis and methods of data collection. Among a number of patient-related factors recognized at risk for post-ERCP pancreatitis in four recent large prospective studies, the combination of female gender, normal serum bilirubin levels and recurrent abdominal pain suggesting sphincter of Oddi dysfunction and previous post-ERCP pancreatitis placed patients at an increasingly higher risk of pancreatitis. Among the technique-related risk factors for post-ERCP pancreatitis, biliary sphincter balloon dilation, difficult cannulation, sphincter of Oddi manometry and pancreatic sphincterotomy have also been recognized as significant risk factors. However, since the case mix in non-selected series does not significantly differ in the different studies, it is logical to assume that the different criteria adopted for defining the post-ERCP pancreatitis play a key role in the reported wide variation of incidence reported for this complication. The occurrence and duration of pain and the amplitude of serum amylase after ERCP are critical points in the definition of post-ERCP pancreatitis. Although a consensus conference identified 24-hour persisting pain associated with hyperamylasemia greater than 3 times the upper reference limit as an indicator of pancreatitis, these two parameters are however considered in a different manner in the studies available up to now. In a prospective study where we calculated the incidence of post-ERCP pancreatitis by using the most widely used criteria, for both occurrence and duration of pancreatic pain and serum amylase amplitude, the incidence of post-procedure pancreatitis ranged from 1.9 to 11.7% depending on the criteria adopted.

Entities:  

Mesh:

Year:  2002        PMID: 12432186

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  14 in total

1.  Laparoendoscopic rendezvous versus ERCP followed by laparoscopic cholecystectomy for the management of cholecysto-choledocholithiasis: a retrospectively cohort study.

Authors:  Yawei Qian; Jianglin Xie; Ping Jiang; Yuchun Yin; Quan Sun
Journal:  Surg Endosc       Date:  2019-08-19       Impact factor: 4.584

2.  Comparative analysis of endoscopic precut conventional and needle knife sphincterotomy.

Authors:  Andrzej Jamry
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 3.  Current status of laparoendoscopic rendezvous in the treatment of cholelithiasis with concomitant choledocholithiasis.

Authors:  Ioannis Baloyiannis; George Tzovaras
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

4.  Use of the urinary trypsinogen-2 dip stick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography.

Authors:  S Sankaralingam; C Wesen; M Barawi; R Galera; L Lloyd
Journal:  Surg Endosc       Date:  2007-03-01       Impact factor: 4.584

Review 5.  Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.

Authors:  Frances Tse; Jasmine Liu; Yuhong Yuan; Paul Moayyedi; Grigorios I Leontiadis
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

6.  Insulin Resistance as a Novel Risk Factor for Post-ERCP Pancreatitis: A Pilot Study.

Authors:  Ali Riza Koksal; Salih Boga; Huseyin Alkim; Mehmet Bayram; Meltem Ergun; Canan Alkim
Journal:  Dig Dis Sci       Date:  2016-03-19       Impact factor: 3.199

7.  Laparo-endoscopic "Rendezvous" to treat cholecysto-choledocolithiasis: Effective, safe and simplifies the endoscopist's work.

Authors:  Gaetano La Greca; Francesco Barbagallo; Michele Di Blasi; Andrea Chisari; Rosario Lombardo; Rosario Bonaccorso; Saverio Latteri; Andrea Di Stefano; Domenico Russello
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

8.  Effects of contrast media on the hepato-pancreato-biliary system.

Authors:  Omer Topcu; Atilla Kurt; Isilay Nadir; Sema Arici; Ayhan Koyuncu; Cengiz Aydin
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

Review 9.  Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.

Authors:  Frances Tse; Yuhong Yuan; Paul Moayyedi; Grigorios I Leontiadis
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

10.  Do the changes in the serum levels of IL-2, IL-4, TNFalpha, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?

Authors:  Guldem Kilciler; Ugur Musabak; Sait Bagci; Zeki Yesilova; Ahmet Tuzun; Ahmet Uygun; Mustafa Gulsen; Sema Oren; Cagatay Oktenli; Necmettin Karaeren
Journal:  Clin Dev Immunol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.